OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 62
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells
Enrico Gallo, Giovanni Smaldone, Luca Cimmino, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 263-263
Open Access | Times Cited: 2
Enrico Gallo, Giovanni Smaldone, Luca Cimmino, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 263-263
Open Access | Times Cited: 2
Label-Free Surface-Enhanced Raman Spectroscopy with Machine Learning for the Diagnosis of Thyroid Cancer by Using Fine-Needle Aspiration Liquid Samples
Lili Gao, Siyi Wu, Puwasit Wongwasuratthakul, et al.
Biosensors (2024) Vol. 14, Iss. 8, pp. 372-372
Open Access | Times Cited: 5
Lili Gao, Siyi Wu, Puwasit Wongwasuratthakul, et al.
Biosensors (2024) Vol. 14, Iss. 8, pp. 372-372
Open Access | Times Cited: 5
Genomic Landscape and Clinical Features of Advanced Thyroid Carcinoma: A National Database Study in Japan
Soji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 11, pp. 2784-2792
Open Access | Times Cited: 4
Soji Toda, Yukihiko Hiroshima, Hiroyuki Iwasaki, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 11, pp. 2784-2792
Open Access | Times Cited: 4
Enhancing clinical decision-making: A novel nomogram for stratifying cancer-specific survival in middle-aged individuals with follicular thyroid carcinoma utilizing SEER data
Chenghao Zhanghuang, Jinkui Wang, Fengming Ji, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31876-e31876
Open Access | Times Cited: 4
Chenghao Zhanghuang, Jinkui Wang, Fengming Ji, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31876-e31876
Open Access | Times Cited: 4
Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma
Olivia W. Lee, Danielle M. Karyadi, Stephen W. Hartley, et al.
European Thyroid Journal (2025)
Open Access
Olivia W. Lee, Danielle M. Karyadi, Stephen W. Hartley, et al.
European Thyroid Journal (2025)
Open Access
Anaplastic thyroid carcinoma in a 43-year-old female confirmed by metastatic lymph node pathology: A case report
Huanyu Jiang, Lijuan Zhou, Teng Zhao, et al.
Oral Oncology (2025) Vol. 161, pp. 107192-107192
Closed Access
Huanyu Jiang, Lijuan Zhou, Teng Zhao, et al.
Oral Oncology (2025) Vol. 161, pp. 107192-107192
Closed Access
Molecular testing stratifies the risk of structural recurrence in high risk differentiated thyroid cancer: a retrospective cohort study
Jie Liu, Wei-Liang Gao, Xiong Zheng, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Jie Liu, Wei-Liang Gao, Xiong Zheng, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials
Di Sun, Xin Zhang, Xin Jin, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Di Sun, Xin Zhang, Xin Jin, et al.
Thyroid Research (2025) Vol. 18, Iss. 1
Open Access
Genomic Differences in Thyroid Cancers From Primary Sites Versus Distant Metastases in Individual Patients: A Clinical Perspective and Preliminary Report
Yen‐Bo Lin, Hsiang‐Wei Hu, An‐Ko Chung, et al.
Head & Neck (2025)
Closed Access
Yen‐Bo Lin, Hsiang‐Wei Hu, An‐Ko Chung, et al.
Head & Neck (2025)
Closed Access
DNA Methylation Dynamics and Prognostic Implications in Metastatic Differentiated Thyroid Cancer
Helena Rodríguez-Lloveras, Carles Zafón, Carmela Iglesias, et al.
Thyroid (2025)
Closed Access
Helena Rodríguez-Lloveras, Carles Zafón, Carmela Iglesias, et al.
Thyroid (2025)
Closed Access
Identification and validation of the common pathogenesis and hub biomarkers in Papillary thyroid carcinoma complicated by rheumatoid arthritis
Yingming Liu, Xiangjun Kong, Qianshu Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0317369-e0317369
Open Access
Yingming Liu, Xiangjun Kong, Qianshu Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0317369-e0317369
Open Access
Next-Generation Immunohistochemistry in Thyroid Neoplasm: A Practical Review on the Applications in Diagnosis and Molecular Classification
Jonathan Rivera, Jen‐Fan Hang
Endocrine Pathology (2025) Vol. 36, Iss. 1
Open Access
Jonathan Rivera, Jen‐Fan Hang
Endocrine Pathology (2025) Vol. 36, Iss. 1
Open Access
Multi‐Omic Analysis Reveals a Lipid Metabolism Gene Signature and Predicts Prognosis and Chemotherapy Response in Thyroid Carcinoma
Yuqin Tu, Yanchen Chen, Linlong Mo, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
Yuqin Tu, Yanchen Chen, Linlong Mo, et al.
Cancer Medicine (2025) Vol. 14, Iss. 6
Open Access
PIS as a regulator of cellular heterogeneity, prognostic significance, and immune landscape in thyroid cancer
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access
Xianjiang Wu, Lei Dai, Weidong Zhang, et al.
Translational Oncology (2025) Vol. 55, pp. 102296-102296
Closed Access
The Revolution of Targeted Therapies in Thyroid Cancer Treatment: Present and Future Promising Anti-Cancer Drugs
Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Ginesa García‐Rostán
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3663-3663
Open Access
Sara Gil‐Bernabé, Lucía García‐DeLaFuente, Ginesa García‐Rostán
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3663-3663
Open Access
Multigene Detection Analysis of Multifocal Papillary Thyroid Carcinoma
Xiaolian Fang, Peng Luo, Zhentian Kai, et al.
Clinical Endocrinology (2025)
Closed Access
Xiaolian Fang, Peng Luo, Zhentian Kai, et al.
Clinical Endocrinology (2025)
Closed Access
Update on Somatic Genomic Alterations in Follicular Cell-Derived Thyroid Cancers
William Perry, Thomas J. Giordano
Endocrinology and Metabolism Clinics of North America (2025)
Closed Access
William Perry, Thomas J. Giordano
Endocrinology and Metabolism Clinics of North America (2025)
Closed Access
Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement
Sophie Leboulleux, Laura Boucai, Naifa L. Busaidy, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Sophie Leboulleux, Laura Boucai, Naifa L. Busaidy, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
Metabolic Reprogramming in Thyroid Cancer
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 3
Sang Hyeon Ju, Minchul Song, Joung Youl Lim, et al.
Endocrinology and Metabolism (2024) Vol. 39, Iss. 3, pp. 425-444
Open Access | Times Cited: 3
Comprehensive genomic profiling from C‐CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1
Yuki Saito, Hidenori Kage, Kenya Kobayashi, et al.
Clinical Endocrinology (2024) Vol. 101, Iss. 2, pp. 170-179
Open Access | Times Cited: 3
Yuki Saito, Hidenori Kage, Kenya Kobayashi, et al.
Clinical Endocrinology (2024) Vol. 101, Iss. 2, pp. 170-179
Open Access | Times Cited: 3
Systemic treatments for radioiodine-refractory thyroid cancers
P. Chen, Yu Yao, Huiwen Tan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
P. Chen, Yu Yao, Huiwen Tan, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
NF-κB in Thyroid Cancer: An Update
Elvira Crescenzi, Antonio Leonardi, Francesco Pacifico
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11464-11464
Open Access | Times Cited: 3
Elvira Crescenzi, Antonio Leonardi, Francesco Pacifico
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11464-11464
Open Access | Times Cited: 3
The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review
Odysseas Violetis, Panagiota Konstantakou, Ariadni Spyroglou, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 654-654
Open Access | Times Cited: 2
Odysseas Violetis, Panagiota Konstantakou, Ariadni Spyroglou, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 654-654
Open Access | Times Cited: 2
